US$21m for microbiome therapies
EnteroBiotix closes an oversubscribed Series A financing with US$21.5m. The biopharma company will use the proceeds to advance its microbiome drug pipeline.
ADVERTISEMENT
About Uta Mommert
This author has not written his bio yet.
But we are proud to say that Uta Mommert contributed 234 entries already.
Entries by Uta Mommert
Owlstone: US$59m for breath biopsy development
Owlstone Medical has raised US$59m in a Series D financing round. The proceeds will be used to continue development of the companys breath biopsy tests.
EU ends litigation with AstraZeneca
The EU Commission and AstraZeneca have settled their ongoing legal dispute over the supply of COVID-19 vaccine doses. They agreed to a new delivery schedule.
VectivBio expands rare disease pipeline
Swiss rare disease specialist VectivBio Holding AG is taking over US biotech Comet Therapeutics Inc. for an undisclosed amount. Comet focusses on treatments for metabolic diseases.
ADC Therapeutics: US$325m for ADC royalties
ADC Therapeutics is set to receive up to US$325m for a royalty share in its antibody drug conjugates Zynlonta and Cami.
Yet another blow to Mercks cancer hopeful
GSK-partnered Merck is throwing in the towel for a Phase II trial of its immunotherapy contender bintrafusp alfa after disappointing results.
Beckley Psytech: €68m for psychedelic meds
UK-based start-up Beckley Psytech has completed an upsized Series B financing, raising €68m (US$80m). Proceeds will go towards the companys pipeline of psychedelic compounds dedicated to addressing neurological and psychiatric disorders.
Boehringer walks away from CureVac deal
Setback for CureVac: Boehringer Ingelheim halts a 7-year-old €500m lung cancer collaboration with the Tübingen-based biopharmaceutical company.
New vaccine trial targets Covid variants
Vaccine maker Valneva SE announced the initiation of a further Phase III trial for its COVID-19 vaccine candidate VLA2001.
Protein may help control cancer cells
The protein eIF4A3 may hold the key for future cancer treatments, Karolinska researchers find.